BioCentury | May 16, 2017
Distillery Techniques

Biomarkers

...channel tetramerization domain containing 11 (KCTD11) , RAP1A member of RAS oncogene family (RAP1A) and FES proto-oncogene tyrosine kinase (FES)...
...were independently associated with poor survival. In 176 metastatic melanoma patients, low tumor levels of FES...
BioCentury | Dec 6, 2016
Distillery Therapeutics

Infectious disease

...INDICATION: Staphylococcus Cell culture experiments suggest inhibiting bacterial sufA , sufC and other FeS cluster assembly...
...FeS cluster assembly chaperone sufA (sufA); S. aureus FeS cluster assembly ATPase (sufC); S. aureus FeS...
...Medical Center S. aureus FeS assembly ATPase (sufC) S. aureus FeS cluster assembly chaperone sufA (sufA) S. aureus FeS...
BioCentury | Oct 2, 2006
Tools & Techniques

Targeting fibrosis

...possible for Haptogen's antibodies to bind low-molecular-weight targets, like haptens. Haptomics combines Forced Epitope Selection (FES...
...DBDx) - with the development of antibody libraries biased toward the isolation of haptomic antibodies. FES...
BioCentury | May 15, 2006
Strategy

Next-generation protein players

...Develops domain antibodies, or smallest functional binding units of human antibodies Haptogen Forced Epitope Selection (FES...
BioCentury | Oct 25, 2004
Finance

Ebb & Flow

...valuation is striking when compared to computational chemistry/biology and high throughput screening company Evotec OAI (FES:EVT...
BioCentury | May 13, 2004
Company News

Evotec, Guilford discovery deal

...GLFD and Evotec OAI (FES:EVT) partnered to develop small molecules against GLFD targets. EVT will develop...
BioCentury | Dec 8, 2003
Company News

Artemis, Bayer deal

...Exelixis Inc. (EXEL, South San Francisco, Calif.). Artemis Pharmaceuticals GmbH , Cologne, Germany Bayer AG (FES:BAYG...
Items per page:
1 - 7 of 7